Sarah J. Moore

531 total citations
15 papers, 387 citations indexed

About

Sarah J. Moore is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sarah J. Moore has authored 15 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Sarah J. Moore's work include Biochemical and Structural Characterization (4 papers), Occupational and environmental lung diseases (4 papers) and Peptidase Inhibition and Analysis (3 papers). Sarah J. Moore is often cited by papers focused on Biochemical and Structural Characterization (4 papers), Occupational and environmental lung diseases (4 papers) and Peptidase Inhibition and Analysis (3 papers). Sarah J. Moore collaborates with scholars based in United States, Australia and United Kingdom. Sarah J. Moore's co-authors include Jennifer R. Cochran, Alan Leung, Mario Nicola, Gregory B. Peters, Alexander Dobrovic, Damian J. Hussey, Jamie M. Bergen, Melanie Hayden Gephart, Helen Rayburn and Matthew P. Scott and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Sarah J. Moore

14 papers receiving 376 citations

Peers

Sarah J. Moore
Rike Wallbrecher Netherlands
James R. Kintzing United States
S Rijnboutt Netherlands
Arjen van den Berg United States
Rike Wallbrecher Netherlands
Sarah J. Moore
Citations per year, relative to Sarah J. Moore Sarah J. Moore (= 1×) peers Rike Wallbrecher

Countries citing papers authored by Sarah J. Moore

Since Specialization
Citations

This map shows the geographic impact of Sarah J. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah J. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah J. Moore more than expected).

Fields of papers citing papers by Sarah J. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah J. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah J. Moore. The network helps show where Sarah J. Moore may publish in the future.

Co-authorship network of co-authors of Sarah J. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah J. Moore. A scholar is included among the top collaborators of Sarah J. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah J. Moore. Sarah J. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chia, Nicole, Sarah J. Moore, & Ros Hastings. (2025). ISCN 2024: Summary of Revisions and New Nomenclature. Cytogenetic and Genome Research. 165(1). 1–8. 2 indexed citations
2.
Bartoli, Francesco, Giovanni Signore, Lorena Tedeschi, et al.. (2025). Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma. Bioconjugate Chemistry. 36(11). 2436–2447. 1 indexed citations
3.
Moore, Sarah J., Jean McGowan‐Jordan, Adam C. Smith, et al.. (2023). Genome Mapping Nomenclature. Cytogenetic and Genome Research. 163(5-6). 236–246. 13 indexed citations
4.
Moore, Sarah J., et al.. (2020). Progressive Myofibril Reorganization of Human Cardiomyocytes on a Dynamic Nanotopographic Substrate. ACS Applied Materials & Interfaces. 12(19). 21450–21462. 27 indexed citations
6.
Moore, Sarah J., et al.. (2019). Engineered Fn3 protein has targeted therapeutic effect on mesothelin‐expressing cancer cells and increases tumor cell sensitivity to chemotherapy. Biotechnology and Bioengineering. 117(2). 330–341. 9 indexed citations
7.
Moore, Sarah J., et al.. (2018). Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding. PLoS ONE. 13(5). e0197029–e0197029. 8 indexed citations
8.
Klebe, Sonja, Sarita Prabhakaran, Sarah J. Moore, et al.. (2018). Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data. Pathology. 50(6). 629–634. 7 indexed citations
9.
Moore, Sarah J., et al.. (2013). Engineering Agatoxin, a Cystine-Knot Peptide from Spider Venom, as a Molecular Probe for In Vivo Tumor Imaging. PLoS ONE. 8(4). e60498–e60498. 38 indexed citations
10.
Moore, Sarah J., Melanie Hayden Gephart, Jamie M. Bergen, et al.. (2013). Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma. Proceedings of the National Academy of Sciences. 110(36). 14598–14603. 56 indexed citations
11.
Moore, Sarah J. & Jennifer R. Cochran. (2012). Engineering Knottins as Novel Binding Agents. Methods in enzymology on CD-ROM/Methods in enzymology. 503. 223–251. 44 indexed citations
12.
Jiang, Han, Sarah J. Moore, Zibo Li, et al.. (2012). A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging. Amino Acids. 44(2). 673–681. 9 indexed citations
13.
Moore, Sarah J., Alan Leung, & Jennifer R. Cochran. (2011). Knottins: disulfide-bonded therapeutic and diagnostic peptides. Drug Discovery Today Technologies. 9(1). e3–e11. 62 indexed citations
14.
Thompson, K.A., et al.. (2003). Operational experience with model-based steering in the SLC Linac. 1675–1677.
15.
Hussey, Damian J., Mario Nicola, Sarah J. Moore, Gregory B. Peters, & Alexander Dobrovic. (1999). The (4;11)(q21;p15) Translocation Fuses the NUP98 andRAP1GDS1 Genes and Is Recurrent in T-Cell Acute Lymphocytic Leukemia. Blood. 94(6). 2072–2079. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026